Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Allergy ; 38(12): 1959-68, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19037968

ABSTRACT

BACKGROUND: Increased levels of serum IgE are associated with greater asthma prevalence and disease severity. IgE depletion using an anti-IgE monoclonal antibody has met with success in the treatment of moderate-to-severe and severe persistent allergic asthma. OBJECTIVE: To test whether B cell-targeted therapy is a more effective treatment for airway hyperresponsiveness (AHR) in a murine model compared with IgE-depletion. METHODS: We delivered soluble mTACI-Ig, a receptor for the B cell survival factors BLyS (B Lymphocyte Stimulator) and APRIL (A PRoliferation-Inducing Ligand), or anti-IgE to allergen-sensitized mice before airway challenge with allergen. RESULTS: mTACI-Ig treatment reduced circulating mature B cell levels in the blood, while anti-IgE treatment had no effect on B cell counts. Both mTACI-Ig and anti-IgE decreased the levels of total and allergen-specific IgE in the serum. Histopathologic analysis of lungs showed a reduction in disease severity scores for both treatment groups, but results were more pronounced in mTACI-Ig-treated mice. Neutrophil and eosinophil numbers in the bronchoalveolar lavage (BAL) were significantly reduced following mTACI-Ig treatment, but not after anti-IgE delivery. BLyS and APRIL blockade also resulted in a significant decrease in IL-4 and eotaxin mRNA and IL-4 and KC protein levels in total lung homogenates and BAL fluid, respectively. Finally, mTACI-Ig treatment was more effective than anti-IgE treatment in reducing AHR to inhaled antigen. CONCLUSIONS: Our data demonstrate that delivery of mTACI-Ig is a more effective treatment than anti-IgE mAb in a murine model of AHR.


Subject(s)
Asthma/prevention & control , Recombinant Fusion Proteins/therapeutic use , Allergens/adverse effects , Animals , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/therapeutic use , Asthma/blood , Asthma/etiology , Asthma/immunology , B-Cell Activating Factor/genetics , B-Lymphocytes/immunology , Bronchoalveolar Lavage Fluid/immunology , Chemokines/genetics , Chemokines/metabolism , Disease Models, Animal , Eosinophils/immunology , Immunoglobulin E/blood , Immunoglobulin E/immunology , Inflammation/pathology , Injections, Intraperitoneal , Interleukin-4/genetics , Interleukin-4/metabolism , Lung/metabolism , Lung/pathology , Mice , Mice, Inbred BALB C , Neutrophils/immunology , Ovalbumin/adverse effects , RNA, Messenger/genetics , Recombinant Fusion Proteins/administration & dosage , Tumor Necrosis Factor Ligand Superfamily Member 13/genetics
2.
Immunity ; 15(2): 289-302, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11520463

ABSTRACT

BLyS and APRIL have similar but distinct biological roles, mediated through two known TNF receptor family members, TACI and BCMA. We show that mice treated with TACI-Ig and TACI-Ig transgenic mice have fewer transitional T2 and mature B cells and reduced levels of circulating immunoglobulin. TACI-Ig treatment inhibits both the production of collagen-specific Abs and the progression of disease in a mouse model of rheumatoid arthritis. In BLyS-deficient mice, B cell development is blocked at the transitional T1 stage such that virtually no mature B cells are present, while B-1 cell numbers are relatively normal. These findings further elucidate the roles of BLyS and APRIL in modulating B cell development and suggest that BLyS is required for the development of most but not all mature B cell populations found in the periphery.


Subject(s)
Autoimmune Diseases/etiology , B-Lymphocytes/immunology , Membrane Proteins , Receptors, Tumor Necrosis Factor/metabolism , Animals , Antibody Formation , Arthritis, Rheumatoid/etiology , Arthritis, Rheumatoid/immunology , Autoantibodies/blood , B-Cell Activation Factor Receptor , B-Lymphocytes/classification , Cell Differentiation , Cell Lineage , Collagen/immunology , Homozygote , Immunoglobulins/blood , Mice , Mice, Transgenic , Phenotype , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor/immunology , Transmembrane Activator and CAML Interactor Protein
3.
Nature ; 408(6808): 57-63, 2000 Nov 02.
Article in English | MEDLINE | ID: mdl-11081504

ABSTRACT

Cytokines are important in the regulation of haematopoiesis and immune responses, and can influence lymphocyte development. Here we have identified a class I cytokine receptor that is selectively expressed in lymphoid tissues and is capable of signal transduction. The full-length receptor was expressed in BaF3 cells, which created a functional assay for ligand detection and cloning. Conditioned media from activated human CD3+ T cells supported proliferation of the assay cell line. We constructed a complementary DNA expression library from activated human CD3+ T cells, and identified a cytokine with a four-helix-bundle structure using functional cloning. This cytokine is most closely related to IL2 and IL15, and has been designated IL21 with the receptor designated IL21 R. In vitro assays suggest that IL21 has a role in the proliferation and maturation of natural killer (NK) cell populations from bone marrow, in the proliferation of mature B-cell populations co-stimulated with anti-CD40, and in the proliferation of T cells co-stimulated with anti-CD3.


Subject(s)
B-Lymphocytes/immunology , Interleukins/physiology , Killer Cells, Natural/immunology , Receptors, Interleukin/physiology , T-Lymphocytes/immunology , Amino Acid Sequence , Animals , Bone Marrow Cells , CD40 Antigens/metabolism , Cell Line , Cloning, Molecular , Expressed Sequence Tags , Humans , Interleukin-21 Receptor alpha Subunit , Interleukins/genetics , Interleukins/isolation & purification , Leukopoiesis , Ligands , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Protein Conformation , Receptors, Interleukin/genetics , Receptors, Interleukin/isolation & purification , Receptors, Interleukin-21 , Tissue Distribution
4.
Nature ; 404(6781): 995-9, 2000 Apr 27.
Article in English | MEDLINE | ID: mdl-10801128

ABSTRACT

B cells are important in the development of autoimmune disorders by mechanisms involving dysregulated polyclonal B-cell activation, production of pathogenic antibodies, and co-stimulation of autoreactive T cells. zTNF4 (BLyS, BAFF, TALL-1, THANK) is a member of the tumour necrosis factor (TNF) ligand family that is a potent co-activator of B cells in vitro and in vivo. Here we identify two receptors for zTNF4 and demonstrate a relationship between zTNF4 and autoimmune disease. Transgenic animals overexpressing zTNF4 in lymphoid cells develop symptoms characteristic of systemic lupus erythaematosus (SLE) and expand a rare population of splenic B-Ia lymphocytes. In addition, circulating zTNF4 is more abundant in NZBWF1 and MRL-lpr/lpr mice during the onset and progression of SLE. We have identified two TNF receptor family members, TACI and BCMA, that bind zTNF4. Treatment of NZBWF1 mice with soluble TACI-Ig fusion protein inhibits the development of proteinuria and prolongs survival of the animals. These findings demonstrate the involvement of zTNF4 and its receptors in the development of SLE and identify TACI-Ig as a promising treatment of autoimmune disease in humans.


Subject(s)
Autoimmune Diseases/metabolism , B-Lymphocytes/metabolism , Lupus Erythematosus, Systemic/metabolism , Membrane Proteins/metabolism , Receptors, Antigen, B-Cell/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Amino Acid Sequence , Animals , Autoimmune Diseases/immunology , B-Cell Activating Factor , B-Cell Maturation Antigen , COS Cells , Cells, Cultured , Female , Humans , Immunoglobulin G/metabolism , Immunoglobulin M/metabolism , Lupus Erythematosus, Systemic/immunology , Lymphocyte Count , Mice , Mice, Transgenic , Molecular Sequence Data , Receptors, Antigen, B-Cell/immunology , T-Lymphocytes , Transmembrane Activator and CAML Interactor Protein , Tumor Necrosis Factor-alpha/metabolism
6.
J Biol Chem ; 267(35): 25208-12, 1992 Dec 15.
Article in English | MEDLINE | ID: mdl-1460020

ABSTRACT

Glutamine:fructose-6-phosphate amidotransferase (GFAT) has recently been shown to be an insulin-regulated enzyme that plays a key role in the induction of insulin resistance in cultured cells. As a first step in understanding the molecular regulation of this enzyme the human form of this enzyme has been cloned and the functional protein has been expressed in Escherichia coli. A 3.1-kilobase cDNA was isolated which contains the complete coding region of 681 amino acids. Expression of the cDNA in E. coli produced a protein of approximately 77 kDa and increased GFAT activity 4.5-fold over endogenous bacterial levels. Recombinant GFAT activity was inhibited 51% by UDP-GlcNAc whereas bacterial GFAT activity was insensitive to inhibition by UDP-GlcNAc. On the basis of these results we conclude that: 1) functional human GFAT protein was expressed, and 2) the cloned human cDNA encodes both the catalytic and regulatory domains of GFAT since the recombinant GFAT was sensitive to UDP-GlcNAc. Overall, the development of cloned GFAT molecular probes should provide new insights into the development of insulin resistance by allowing quantitation of GFAT mRNA levels in pathophysiological states such as non-insulin-dependent diabetes mellitus and obesity.


Subject(s)
DNA/genetics , Escherichia coli/genetics , Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA/isolation & purification , Electrophoresis, Polyacrylamide Gel , Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/isolation & purification , Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/metabolism , Humans , Kinetics , Molecular Sequence Data , Molecular Weight , Oligodeoxyribonucleotides , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid
7.
Infect Immun ; 60(10): 4309-21, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1398941

ABSTRACT

Using immunoblots, we identified proteins of Borrelia burgdorferi recognized by sera from 62 patients with either acute or chronic Lyme disease. In all groups studied, the 41-kDa flagellar protein and a relatively minor 93-kDa protein (p93) were the most commonly recognized antigens in patients with acute and chronic disease due to B. burgdorferi. A murine monoclonal antibody (MAb 181.1) was developed against p93, and the antigen was detected by immunoblot analysis in four European and American strains of B. burgdorferi. On two-dimensional gel electrophoresis, p93 had an apparent pI of 6.8. Immunoelectronmicroscopy with MAb 181.1 demonstrated that p93 is located within the protoplasmic cylinder compartment of the organism. The gene encoding p93 was retrieved from a phage expression library. The derived amino acid sequence of p93 confirmed chemical characterization of the antigen, including its amino-terminal peptide sequence. The derived amino acid sequence predicted it to be predominantly alpha helical. A prominent antigenic domain located at the carboxy portion of the protein was recognized by human and rabbit polyclonal antisera and human (MAb D4) and mouse (MAb 181.1) MAbs.


Subject(s)
Antigens, Bacterial/analysis , Bacterial Proteins/analysis , Borrelia burgdorferi Group/immunology , Amino Acid Sequence , Antibodies, Monoclonal/immunology , Bacterial Proteins/genetics , Bacterial Proteins/immunology , Base Sequence , Humans , Molecular Sequence Data
8.
Infect Immun ; 59(6): 1911-5, 1991 Jun.
Article in English | MEDLINE | ID: mdl-2037351

ABSTRACT

The major outer surface membrane protein of Borrelia burgdorferi, OspA, is one of several antigens recognized by sera from some patients in the chronic phase of Lyme borreliosis. We have expressed the OspA open reading frame in Escherichia coli and generated a series of deletion constructs of the gene and expressed them as trpE fusion proteins in E. coli. These constructs were used to identify antibody-binding sites of both rabbit antiserum and mouse monoclonal antibodies (MAbs) directed against OspA. All antibodies tested failed to bind to a fusion protein containing the first 61 amino acids of OspA, suggesting that the amino-terminal domain of OspA is unexposed to the cell surface. The binding site for one MAb, 184.1, was identified in a region centered around amino acid 61, while the binding site for MAb 105.5 was identified in a region centered around amino acids 214 to 217. Sera from two patients which were reactive to OspA identified distinct epitopes that lie between those recognized by our MAbs.


Subject(s)
Bacterial Outer Membrane Proteins/immunology , Binding Sites, Antibody/immunology , Borrelia burgdorferi Group/immunology , Animals , Antibodies, Monoclonal/immunology , Bacterial Outer Membrane Proteins/genetics , Base Sequence , Borrelia burgdorferi Group/genetics , Chromosome Deletion , Electrophoresis, Polyacrylamide Gel , Escherichia coli/genetics , Gene Expression/genetics , Genes, Bacterial/genetics , Humans , Immunoblotting , Lyme Disease/immunology , Mice , Molecular Sequence Data , Open Reading Frames/genetics , Rabbits , Recombinant Fusion Proteins/immunology
9.
Oncogene ; 4(6): 677-83, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2543940

ABSTRACT

The rel oncogene from the avian reticuloendotheliosis virus strain T is a 59 kd phosphoprotein localized primarily to the cytoplasm of transformed cells. Recently, the v-rel protein was shown to associate with several cellular proteins with molecular weights of 124 kd, 115 kd, and 36 kd. We have analysed the subcellular distribution of v-rel protein complexes after biochemical fractionation of [35S]methionine and [32P]orthophosphate labeled cells. Our results demonstrate that the v-rel protein coprecipitates with a characteristic set of proteins, some of which are distinct to nuclear or cytoplasmic fractions. We also demonstrate that the normal cellular homolog of the viral rel protein, c-rel, coprecipitates with several cellular proteins from normal chick hematopoietic tissue. These cellular proteins have apparent molecular weights similar to those which are coprecipitated with v-rel from cytoplasmic fractions. Our results demonstrate that both v-rel and c-rel interact with a variety of cellular proteins and suggest that this association is important for the function or regulation of the rel protein.


Subject(s)
Proto-Oncogene Proteins/metabolism , Reticuloendotheliosis virus/genetics , Retroviridae Proteins/metabolism , Retroviridae/genetics , Animals , Cell Fractionation , Cell Line , Cell Line, Transformed , Cell Nucleus/metabolism , Centrifugation, Density Gradient , Cytoplasm/metabolism , Molecular Weight , Oncogene Proteins v-rel , Phosphorylation , Precipitin Tests , Protein Binding , Proto-Oncogene Proteins c-rel , Reticuloendotheliosis virus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...